Evonik: Core specialty chemicals business

Evonik is one of the world's leading specialty chemicals companies. Profitable growth and a sustained increase in the value of the company form the heart of our strategy, which is supported by our owners, RAG-Stiftung (74.99 percent) and funds managed by CVC Capital Partners (25.01 percent). Our specialty chemicals activities focus on high-growth megatrends—especially health, nutrition, resource efficiency, and globalization—and our goal is to enter attractive future-oriented markets.

In 2011 Evonik’s roughly 33,000 employees generated sales of €14.5 billion and an operating result (EBITDA) of €2.8 billion. More than 70 percent of sales are generated outside Germany, providing convincing evidence that our business is global.

Megatrends

What will tomorrow’s world be like? What will society need in ten or twenty years time? Addressing such issues is essential to ensure timely identification of trends and future markets. That’s what Evonik does. We have an idea of the future.more

Products & Solutions

Developing ideas to market readiness as quickly as possible is both a challenge and an economic necessity. Ensuring that they offer the maximum benefit for customers and society is at least equally difficult. The best way to achieve these goals is through collaboration. We are convinced that proximity to customers and the joint search for solutions are the keys to success.more